Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expression.

Bhang HE, Gabrielson KL, Laterra J, Fisher PB, Pomper MG.

Nat Med. 2011 Jan;17(1):123-9. doi: 10.1038/nm.2269.

2.

Tumor-specific expression and detection of a CEST reporter gene.

Minn I, Bar-Shir A, Yarlagadda K, Bulte JW, Fisher PB, Wang H, Gilad AA, Pomper MG.

Magn Reson Med. 2015 Aug;74(2):544-9. doi: 10.1002/mrm.25748.

3.

The EZC-prostate model: noninvasive prostate imaging in living mice.

Xie X, Luo Z, Slawin KM, Spencer DM.

Mol Endocrinol. 2004 Mar;18(3):722-32.

PMID:
14684850
4.

Development of a universal anti-polyethylene glycol reporter gene for noninvasive imaging of PEGylated probes.

Chuang KH, Wang HE, Cheng TC, Tzou SC, Tseng WL, Hung WC, Tai MH, Chang TK, Roffler SR, Cheng TL.

J Nucl Med. 2010 Jun;51(6):933-41. doi: 10.2967/jnumed.109.071977.

5.

Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters.

Iyer M, Wu L, Carey M, Wang Y, Smallwood A, Gambhir SS.

Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14595-600.

6.

MMTV-associated transcription factor binding sites increase nm23-H1 metastasis suppressor gene expression in human breast carcinoma cell lines.

Ouatas T, Clare SE, Hartsough MT, De La Rosa A, Steeg PS.

Clin Exp Metastasis. 2002;19(1):35-42.

PMID:
11918081
7.

Reporter gene imaging.

Youn H, Chung JK.

AJR Am J Roentgenol. 2013 Aug;201(2):W206-14. doi: 10.2214/AJR.13.10555. Review.

PMID:
23883235
8.

Targeting gene expression selectively in cancer cells by using the progression-elevated gene-3 promoter.

Su ZZ, Sarkar D, Emdad L, Duigou GJ, Young CS, Ware J, Randolph A, Valerie K, Fisher PB.

Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1059-64.

9.

Noninvasive in vivo monitoring of neuronal differentiation using reporter driven by a neuronal promoter.

Hwang DW, Kang JH, Jeong JM, Chung JK, Lee MC, Kim S, Lee DS.

Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):135-45.

PMID:
17885755
10.

Advanced two-step transcriptional amplification as a novel method for cancer-specific gene expression and imaging.

Watanabe M, Ueki H, Ochiai K, Huang P, Kobayashi Y, Nasu Y, Sasaki K, Kaku H, Kashiwakura Y, Kumon H.

Oncol Rep. 2011 Oct;26(4):769-75. doi: 10.3892/or.2011.1371.

PMID:
21725614
11.

Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.

Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ.

Breast Cancer Res Treat. 2009 Sep;117(1):45-54. doi: 10.1007/s10549-008-0163-6.

PMID:
18791823
12.

Dual transgenic reporter mice as a tool for monitoring expression of glial fibrillary acidic protein.

Cho W, Hagemann TL, Johnson DA, Johnson JA, Messing A.

J Neurochem. 2009 Jul;110(1):343-51. doi: 10.1111/j.1471-4159.2009.06146.x.

13.
15.

Transcriptional targeting in ovarian cancer cells using the human epididymis protein 4 promoter.

Berry NB, Cho YM, Harrington MA, Williams SD, Foley J, Nephew KP.

Gynecol Oncol. 2004 Mar;92(3):896-904.

PMID:
14984958
16.

P21-driven multifusion gene system for evaluating the efficacy of histone deacetylase inhibitors by in vivo molecular imaging and for transcription targeting therapy of cancer mediated by histone deacetylase inhibitor.

Hsieh YJ, Hwu L, Chen YC, Ke CC, Chen FD, Wang HE, Lin KP, Yeh HH, Chang CW, Liu RS.

J Nucl Med. 2014 Apr;55(4):678-85. doi: 10.2967/jnumed.113.126573.

17.

Differential regulation of the mouse and human Wnt5a alternative promoters A and B.

Katula KS, Joyner-Powell NB, Hsu CC, Kuk A.

DNA Cell Biol. 2012 Nov;31(11):1585-97. doi: 10.1089/dna.2012.1698.

18.

A bioluminescent transposon reporter-trap identifies tumor-specific microenvironment-induced promoters in Salmonella for conditional bacterial-based tumor therapy.

Flentie K, Kocher B, Gammon ST, Novack DV, McKinney JS, Piwnica-Worms D.

Cancer Discov. 2012 Jul;2(7):624-37. doi: 10.1158/2159-8290.CD-11-0201.

19.

Androgen-independent molecular imaging vectors to detect castration-resistant and metastatic prostate cancer.

Jiang ZK, Sato M, Wei LH, Kao C, Wu L.

Cancer Res. 2011 Oct 1;71(19):6250-60. doi: 10.1158/0008-5472.CAN-11-1520.

20.

[Comparative analysis of activity of different promoters for NIS gene expression in melanoma cells].

Kuz'mich AI, Kopantsev EP, Vinogradova TV, Sverdlov ED.

Mol Biol (Mosk). 2014 Jan-Feb;48(1):142-52. Russian.

PMID:
25842835

Supplemental Content

Support Center